Drugs

Combination Diuretic Therapy in Severe Congestive Heart Failure
pp. 165-172(8)
Authors: Dormans T.P.; Gerlag P.G.; Russel F.G.; Smits P.

5-HT Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Comparison of Their Pharmacology and Clinical Efficacy
pp. 173-189(17)
Authors: Gregory R.E.; Ettinger D.S.

Guidelines for the Treatment of Acidaemia with THAM
pp. 191-224(34)
Authors: Capan L.; Nahas G.G.; Manne J.; Sutin K.M.; Helwig H.; Fermon C.; Gaab M.; Streat S.; Pfenninger E.; Wiklund L.; Wetterberg T.; Wahlander S.; Holmdahl M.; Yellin P.; Turndorf H.; Brasch H.; Kanchuger M.

Oral Antidiabetic Agents: A Guide to Selection
pp. 225-236(12)
Authors: Scheen J.; Lefèbvre P.J.

Treatment of Childhood Asthma: Options and Rationale for Inhaled Therapy
pp. 237-252(16)
Authors: Powell C.V.E.; Everard M.L.

Transdermal Testosterone
pp. 253-258(6)
Authors: McClellan K.J.; Goa K.L.

Transdermal Testosterone: A Viewpoint by Adrian S. Dobs
pp. 259-259(1)
Author: Dobs A.S.

Transdermal Testosterone: A Viewpoint by A. Wayne Meikle
pp. 259-259(1)
Author: Meikle A.W.

Rabeprazole
pp. 261-267(7)
Authors: Prakash A.; Faulds D.

Rabeprazole: A Viewpoint by Simmy Bank
pp. 268-268(1)
Author: Bank S.

Rabeprazole: A Viewpoint by Noriaki Takeguchi
pp. 268-268(1)
Author: Takeguchi N.

Fexofenadine
pp. 269-274(6)
Authors: Markham A.; Wagstaff A.J.

Fexofenadine: A Viewpoint by Stanley P. Galant
pp. 275-276(2)
Author: Galant S.P.

Fexofenadine: A Viewpoint by F. Estelle R. Simons
pp. 275-276(2)
Authors: Estelle F.; Simons R.

Zopiclone: An Update of its Pharmacology, Clinical Efficacy and Tolerability in the Treatment of Insomnia
pp. 277-302(26)
Authors: Noble S.; Langtry H.D.; Lamb H.M.

Formoterol: An Update of its Pharmacological Properties and Therapeutic Efficacy in the Management of Asthma
pp. 303-322(20)
Authors: Bartow R.A.; Brogden R.N.